Literature DB >> 21528065

Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene.

Xiao-Bo Guo1, Chang-Qing Jing, Le-Ping Li, Li Zhang, Yu-Long Shi, Jin-Shen Wang, Jing-Lei Liu, Chen-Sheng Li.   

Abstract

AIM: To evaluate the biological and clinical characteristics of miR-622 in gastric cancer.
METHODS: We analyzed the expression of miR-622 in 57 pair matched gastric neoplastic and adjacent non-neoplastic tissues by quantitative real-time polymerase chain reaction. Functional analysis of miR-622 expression was assessed in vitro in gastric cancer cell lines with miR-622 precursor and inhibitor. The roles of miR-622 in tumorigenesis and tumor metastasis were analyzed using a stable miR-622 expression plasmid in nude mice. A luciferase reporter assay was used to assess the effect of miR-622 on inhibitor of growth family, member 1 (ING1) expression.
RESULTS: Expression of miR-622 was down-regulated in gastric cancer. MiR-622 was found involved in differentiation and lymphatic metastasis in human gastric cancer. Ectopic expression of miR-622 promoted invasion, tumorigenesis and metastasis of gastric cancer cells both in vitro and in vivo. ING1 is a direct target of miR-622.
CONCLUSION: These findings help clarify the molecular mechanisms involved in gastric cancer metastasis and indicate that miR-622 modulation may be a bona fide treatment of gastric cancer.

Entities:  

Keywords:  Gastric cancer; Inhibitor of growth family member 1; Metastasis; MiR-622; MicroRNA

Mesh:

Substances:

Year:  2011        PMID: 21528065      PMCID: PMC3080726          DOI: 10.3748/wjg.v17.i14.1895

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Identification of novel genes coding for small expressed RNAs.

Authors:  M Lagos-Quintana; R Rauhut; W Lendeckel; T Tuschl
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

Review 2.  The leukocyte cytoskeleton in cell migration and immune interactions.

Authors:  Miguel Vicente-Manzanares; David Sancho; María Yáñez-Mó; Francisco Sánchez-Madrid
Journal:  Int Rev Cytol       Date:  2002

Review 3.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  An extensive class of small RNAs in Caenorhabditis elegans.

Authors:  R C Lee; V Ambros
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

Review 6.  Surgical issues after neoadjuvant treatment for gastric cancer.

Authors:  D D'Ugo; R Persiani; M Zoccali; F Cananzi; V Vigorita; P Mazzeo; A Tufo; A Biondi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-04       Impact factor: 3.507

Review 7.  Hepatocellular carcinoma: molecular pathways and new therapeutic targets.

Authors:  Lewis R Roberts; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

8.  Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

Authors:  Norio Iizuka; Masaaki Oka; Hisafumi Yamada-Okabe; Minekatsu Nishida; Yoshitaka Maeda; Naohide Mori; Takashi Takao; Takao Tamesa; Akira Tangoku; Hisahiro Tabuchi; Kenji Hamada; Hironobu Nakayama; Hideo Ishitsuka; Takanobu Miyamoto; Akira Hirabayashi; Shunji Uchimura; Yoshihiko Hamamoto
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

9.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

Review 10.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

View more
  32 in total

1.  Association between gastric cancer and -1993 polymorphism of TBX21 gene.

Authors:  Le-Hui Zhang; Qin Li; Peng Li; Sheng-Tao Zhu; Jing Wang; Hong-Li Yang; Chang-Qing Xu; Xiu-Hua Guo
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

Review 2.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

3.  MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells.

Authors:  Rui Zhang; Hui Luo; Shuai Wang; Zhengxin Chen; Lingyang Hua; Hong-Wei Wang; Wanghao Chen; Yongsheng Yuan; Xiaobin Zhou; Daqian Li; Shuying Shen; Tao Jiang; Yongping You; Ning Liu; Huibo Wang
Journal:  J Neurooncol       Date:  2014-09-26       Impact factor: 4.130

Review 4.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

5.  microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma.

Authors:  Wei-Hua Song; Xiao-Jun Feng; Shao-Juan Gong; Jian-Ming Chen; Shou-Mei Wang; Dong-Juan Xing; Ming-Hua Zhu; Shu-Hui Zhang; Ai-Min Xu
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 6.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

7.  The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.

Authors:  Jun Liu; Yongping Lin; Haihong Yang; Qiuhua Deng; Guoqin Chen; Jianxing He
Journal:  Tumour Biol       Date:  2011-07-22

8.  Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma.

Authors:  Xinzhi Wang; Zhenxue Xin; Yinfu Xu; Jinbang Ma
Journal:  Tumour Biol       Date:  2015-11-23

9.  Long non-coding RNA GPR65-1 is up-regulated in gastric cancer and promotes tumor growth through the PTEN-AKT-slug signaling pathway.

Authors:  Yansen Li; Zhanlong Shen; Bo Wang; Chunxiang Ye; Zhiyong Lai; Hongpeng Jiang; Zhu Wang; Kewei Jiang; Yingjiang Ye; Shan Wang
Journal:  Cell Cycle       Date:  2018-04-02       Impact factor: 4.534

10.  miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.

Authors:  Muhammad Riaz; Marijn T M van Jaarsveld; Antoinette Hollestelle; Wendy J C Prager-van der Smissen; Anouk A J Heine; Antonius W M Boersma; Jingjing Liu; Jean Helmijr; Bahar Ozturk; Marcel Smid; Erik A Wiemer; John A Foekens; John W M Martens
Journal:  Breast Cancer Res       Date:  2013-04-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.